Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Robert Rohrberg"'
Autor:
Matthias P.A. Ebert, Friedrich Overkamp, Erdem Göker, Dirk Reuter, Dirk Strumberg, Jens T. Siveke, Suayip Yalcin, Wolfgang E. Berdel, Markus Dommach, M. Bulitta, R.D. Hofheinz, Michael Kneba, Andrea Kerkhoff, Tilman Steinmetz, Frank Schlegel, Beate Schultheis, S De Dosso, Wolfgang E. Schmidt, Dirk Behringer, Robert Rohrberg
WOS: 000411827200016
PubMed ID: 28961832
Background: This randomized study was designed to investigate the superiority of gemcitabine (gem) plus nimotuzumab (nimo), an anti-epidermal growth factor receptor monoclonal antibody, compared with
PubMed ID: 28961832
Background: This randomized study was designed to investigate the superiority of gemcitabine (gem) plus nimotuzumab (nimo), an anti-epidermal growth factor receptor monoclonal antibody, compared with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db783c3dbb63d2b9a38e9f52239add02
http://hdl.handle.net/11655/15082
http://hdl.handle.net/11655/15082
Autor:
H. Tilman Steinmetz, Jochen Eggert, Friedhelm Breuer, Heidi Eustermann, Hans-Werner Tessen, Lothar Thomas, Antonis Tsamaloukas, Stephan Schmitz, Jörg Wiegand, Robert Rohrberg
Publikováno v:
Supportive Care in Cancer. 19:261-269
This study aimed to prove the usefulness of the diagnostic plot, using the haemoglobin content of reticulocytes as a measure of functional iron deficiency (FID) and the ferritin index as a measure of iron availability, to customise anaemia treatment
Autor:
Barbara F, Eichhorst, Raymonde, Busch, Stephan, Stilgenbauer, Martina, Stauch, Manuela A, Bergmann, Matthias, Ritgen, Nicole, Kranzhöfer, Robert, Rohrberg, Ulrike, Söling, Oswald, Burkhard, Anne, Westermann, Valentin, Goede, Carmen D, Schweighofer, Kirsten, Fischer, Anna-Maria, Fink, Clemens M, Wendtner, Günter, Brittinger, Hartmut, Döhner, Bertold, Emmerich, Michael, Hallek, M, Sandmann
Publikováno v:
Blood. 114:3382-3391
Although chronic lymphocytic leukemia (CLL) is a disease of elderly patients, subjects older than 65 years are heavily underrepresented in clinical trials. The German CLL study group (GCLLSG) initiated a multicenter phase III trial for CLL patients o
Autor:
Rudolf Mueck, Robert Rohrberg, Oliver Weigert, Martin Dreyling, Martin Bentz, Wolfgang Hiddemann, Eckhart Weidmann, Kathleen Jentsch-Ullrich, Christoph von Schilling
Publikováno v:
Leukemia & Lymphoma. 50:716-722
Salvage therapy for patients with mantle cell lymphoma (MCL) remains a challenge. The clinical course is characterised by increasing resistance to conventional chemotherapy and a dismal long-term outcome. On the basis of studies demonstrating synergy
Autor:
Ute Kreibich, Antje Haas, Hartmut Goldschmidt, Wolfram Pönisch, Thomas Boldt, Robert Rohrberg, Dietger Niederwieser, Andreas Schwarzer, Franz Albert Hoffmann, Elke Schwalbe, Thomas Zehrfeld, Jens Uhlig, Marta Rozanski, Ute Ritter, Veronika Schirmer
Publikováno v:
British Journal of Haematology. 143:191-200
Thalidomide is an effective agent for advanced refractory or relapsed multiple myeloma (MM), although dose-limiting toxicity (DLT) may limit its use. This Phase I study found that a combination of low-dose thalidomide with bendamustine and prednisolo
Autor:
Sabine Neser, Antje Haas, Ralph Naumann, Erika Kettner, Robert Rohrberg, Kathrin Haifa Al-Ali, Ursula Haak, Michael Herold, Christian Klinkenstein, Astrid Franke, Mathias Freund, Gottfried Dölken, Ulrich Mey, Ullrich von Grünhagen, Michael Aβmann, Klaus Höffken, Stefanie Srock, Wolfgang Knauf, Thomas Ittel, Andreas Neubauer
Publikováno v:
Journal of Clinical Oncology. 25:1986-1992
Purpose Rituximab has been shown to be active in follicular lymphoma (FL), both as monotherapy and in combination with chemotherapy. We conducted a randomized trial comparing mitoxantrone, chlorambucil, and prednisolone (MCP) chemotherapy plus rituxi
Autor:
Dirk Strumberg, Friedrich Overkamp, Dirk Behringer, Sara De Dosso, Robert Rohrberg, Wolfgang E. Schmidt, Frank Schlegel, Andrea Kerkhoff, N. Iznaga Escobar, Suayib Yalcin, Tania Crombet Ramos, Carmen Valenzuela Silva, Markus Dommach, Lizet Sánchez Valdés, Patricia Lorenzo Luaces, Matthias P.A. Ebert, Erdem Göker, Ralf Hofheinz, Michael Kneba, Beate Schultheis
Publikováno v:
Journal of Clinical Oncology. 35:e15787-e15787
e15787 Background: Nimotuzumab, a unique and affinity differentiated anti-EGFR antibody had been used in combination with gemcitabine on the treatment of pancreatic cancer patients. The aim of the study was to evaluate overall survival. Methods: Pati
Autor:
Matthias Fischer, Wolfgang Ch. Marsch, Albrecht Oehme, Robert Rohrberg, Caroline Oeder, Katharina Waltermann, Danica Lange, Anke Mueller
Publikováno v:
Journal der Deutschen Dermatologischen Gesellschaft. 7:767-769
Autor:
Simone Heyn, Rainer Krahl, Ina Wagner, Barbara Moll, Wolfram Pönisch, Michael Aßmann, Robert Rohrberg, Andreas Schwarzer, Malvina Bourgeois, Gerald Hensel, Haifa Al Ali, Cornelia Becker, Thomas Zehrfeld, Martin Mohren, Uta Schönfelder, Thomas Edelmann, Marion Schmalfeld, Kerstin Löschcke, Nadja Jäkel, Dietger Niederwieser, Hans-Jürgen Hurtz, Franz Albert Hoffmann
Publikováno v:
Journal of cancer research and clinical oncology. 139(3)
Bortezomib (Velcade) is a proteasome inhibitor that has shown important clinical efficacy either as a single agent or in combination with other cytostatic agents in multiple myeloma (MM). In the present protocol, bortezomib was combined with other ac
Autor:
Danica Lange, Caroline Oeder, Katharina Waltermann, Anke Mueller, Albrecht Oehme, Robert Rohrberg, Wolfgang Marsch, Matthias Fischer
Publikováno v:
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG. 7(9)
An infection with Bartonella henselae transmitted from domestic cats to humans by scratching normally leads to cat-scratch disease. When the human host has severe immunosuppression or HIV infection, the potentially life-threatening disease bacillary